Physician profile
Andrew Parrish
NPI 1447754403
$271.49
in general payments reported to CMS, 2019-2025
7 companies · $195 in 2025
The $195 reported for 2025 was less than what a typical Plastic Surgery provider received nationally (typical 2025 total: $380).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $48.40 · 2024: $28.57 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $271.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $271.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $56.75 | 2025 | Phasix Mesh |
| Musculoskeletal Transplant Foundation INC. | $49.13 | 2025 | |
| Kci USA, INC. | $48.40 | 2023 | Prevena Restor Bellaform, V.A.C. Veraflo Cleanse Choice, V.A.C. Dermatac |
| Solventum Corporation | $36.76 | 2025 | Prevena Restor Bellaform, Prevena, V.A.C. Veraflo |
| Axogen | $32.69 | 2024-2025 | Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap, Axoguard Nerve Protector |
| Integra Lifesciences Corporation | $32.64 | 2025 | Integra, Omnigraft, Surgimend |
| Pacira Pharmaceuticals Incorporated | $15.12 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Parrish listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.